The medication has a half-life of approximately five days, meaning therapeutic effects persist for several weeks after the final dose but eventually resolve completely
Forbes and USA Today logos are displayed on the site with no sourcing links
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al
While the medication does much of the work, your food choices during treatment significantly impact both side effect severity and weight loss outcomes
Tirzepatide vs semaglutide Single receptor (GLP-1) 15-17% weight loss average Lower starting dose (0.25mg) Slower titration More established research Tirzepatide : Dual receptor (GLP-1 + GIP) 15-22% weight loss average Higher starting dose (2.5mg) Faster results Newer, less long-term data Winner : Tirzepatide edges out for weight loss effectiveness
Names were changed to protect the patient's identity